Microba Life (Australia) Performance
| MAP Stock | 0.19 0.01 5.56% |
On a scale of 0 to 100, Microba Life holds a performance score of 4. The company secures a Beta (Market Risk) of -0.41, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Microba Life are expected to decrease at a much lower rate. During the bear market, Microba Life is likely to outperform the market. Please check Microba Life's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to make a quick decision on whether Microba Life's current price movements will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Microba Life Sciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Microba Life unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Microba Life Sciences Director Increases Shareholding - TipRanks | 11/19/2024 |
| Begin Period Cash Flow | 32 M |
Microba |
Microba Life Relative Risk vs. Return Landscape
If you would invest 17.00 in Microba Life Sciences on September 20, 2024 and sell it today you would earn a total of 2.00 from holding Microba Life Sciences or generate 11.76% return on investment over 90 days. Microba Life Sciences is generating 0.2448% of daily returns assuming 3.8838% volatility of returns over the 90 days investment horizon. Simply put, 34% of all stocks have less volatile historical return distribution than Microba Life, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Microba Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microba Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Microba Life Sciences, and traders can use it to determine the average amount a Microba Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.063
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MAP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.88 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Microba Life is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Microba Life by adding it to a well-diversified portfolio.
Microba Life Fundamentals Growth
Microba Stock prices reflect investors' perceptions of the future prospects and financial health of Microba Life, and Microba Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Microba Stock performance.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.31 | ||||
| Profit Margin | (1.65) % | ||||
| Operating Margin | (1.31) % | ||||
| Current Valuation | 65.78 M | ||||
| Shares Outstanding | 447.85 M | ||||
| Price To Book | 2.06 X | ||||
| Price To Sales | 7.04 X | ||||
| Revenue | 12.09 M | ||||
| Gross Profit | 2.68 M | ||||
| EBITDA | (17.1 M) | ||||
| Net Income | (19.94 M) | ||||
| Cash And Equivalents | 12.43 M | ||||
| Total Debt | 1.58 M | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | (15.57 M) | ||||
| Earnings Per Share | (0.05) X | ||||
| Total Asset | 58.04 M | ||||
| Retained Earnings | (63.82 M) | ||||
About Microba Life Performance
Assessing Microba Life's fundamental ratios provides investors with valuable insights into Microba Life's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Microba Life is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Microba Life is entity of Australia. It is traded as Stock on AU exchange.Things to note about Microba Life Sciences performance evaluation
Checking the ongoing alerts about Microba Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Microba Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Microba Life has some characteristics of a very speculative penny stock | |
| Microba Life had very high historical volatility over the last 90 days | |
| The company reported the revenue of 12.09 M. Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 2.68 M. | |
| Microba Life Sciences has accumulated about 12.43 M in cash with (15.57 M) of positive cash flow from operations. | |
| Roughly 55.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Microba Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Microba Life's stock is overvalued or undervalued compared to its peers.
- Examining Microba Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Microba Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Microba Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Microba Life's stock. These opinions can provide insight into Microba Life's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Microba Stock Analysis
When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.